ClinVar Miner

Submissions for variant NM_000256.3(MYBPC3):c.2602+2T>G

dbSNP: rs1555121145
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000498966 SCV000590135 likely pathogenic not provided 2017-06-15 criteria provided, single submitter clinical testing A likely pathogenic variant has been identified in the MYBPC3 gene. The c.2602+2 T>G variant has not been published as pathogenic or been reported as benign to our knowledge. This variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This substitution occurs at a nucleotide position that is conserved across species. The c.2602+2 T>G variant is predicted to destroy the canonical splice donor site in intron 25 and cause abnormal gene splicing. Other splice site variants in the MYBPC3 gene have been reported in HGMD in association with cardiomyopathy (Stenson et al., 2014).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.